Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells - PubMed (original) (raw)
. 2013 Dec 15;23(24):6923-7.
doi: 10.1016/j.bmcl.2013.09.037. Epub 2013 Sep 28.
Affiliations
- PMID: 24200808
- DOI: 10.1016/j.bmcl.2013.09.037
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells
Tiziano Tuccinardi et al. Bioorg Med Chem Lett. 2013.
Abstract
An analysis of the main pharmacophoric features present in the still limited number of inhibitors of glucose transporter GLUT1 led to the identification of new oxime-based inhibitors, which proved to be able to efficiently hinder glucose uptake and cell growth in H1299 lung cancer cells. The most important interactions of a representative inhibitor were indicated by a novel computational model of GLUT1, which was purposely developed to explain these results and to provide useful indications for the design and the development of new and more efficient GLUT1 inhibitors.
Keywords: Cancer; Glucose transporter; Glycolysis; Modeling; Warburg effect.
Copyright © 2013. Published by Elsevier Ltd.
Similar articles
- Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer Cells.
Granchi C, Qian Y, Lee HY, Paterni I, Pasero C, Iegre J, Carlson KE, Tuccinardi T, Chen X, Katzenellenbogen JA, Hergenrother PJ, Minutolo F. Granchi C, et al. ChemMedChem. 2015 Nov;10(11):1892-900. doi: 10.1002/cmdc.201500320. Epub 2015 Sep 1. ChemMedChem. 2015. PMID: 26332543 Free PMC article. - A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.
Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H, Colvin R, Ding J, Tong L, Wu S, Hines J, Chen X. Liu Y, et al. Mol Cancer Ther. 2012 Aug;11(8):1672-82. doi: 10.1158/1535-7163.MCT-12-0131. Epub 2012 Jun 11. Mol Cancer Ther. 2012. PMID: 22689530 - Design, Synthesis, and Evaluation of GLUT Inhibitors.
Granchi C, Tuccinardi T, Minutolo F. Granchi C, et al. Methods Mol Biol. 2018;1713:93-108. doi: 10.1007/978-1-4939-7507-5_8. Methods Mol Biol. 2018. PMID: 29218520 Review. - Design of antitumor agents containing carbohydrate based on GLUT1, and evaluation of antiproliferative activity.
Zhang R, Song L, Jiang B, Wang L, Wu N, Guo S, Shi D. Zhang R, et al. Bioorg Med Chem Lett. 2017 Jun 1;27(11):2488-2492. doi: 10.1016/j.bmcl.2017.03.094. Epub 2017 Apr 2. Bioorg Med Chem Lett. 2017. PMID: 28462838 - The progress and development of GLUT1 inhibitors targeting cancer energy metabolism.
Meng Y, Xu X, Luan H, Li L, Dai W, Li Z, Bian J. Meng Y, et al. Future Med Chem. 2019 Sep;11(17):2333-2352. doi: 10.4155/fmc-2019-0052. Future Med Chem. 2019. PMID: 31581916 Review.
Cited by
- Anticancer agents interacting with membrane glucose transporters.
Granchi C, Fortunato S, Minutolo F. Granchi C, et al. Medchemcomm. 2016 Sep 1;7(9):1716-1729. doi: 10.1039/C6MD00287K. Epub 2016 Jul 8. Medchemcomm. 2016. PMID: 28042452 Free PMC article. - Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Liu T, Kishton RJ, Macintyre AN, Gerriets VA, Xiang H, Liu X, Abel ED, Rizzieri D, Locasale JW, Rathmell JC. Liu T, et al. Cell Death Dis. 2014 Oct 16;5(10):e1470. doi: 10.1038/cddis.2014.431. Cell Death Dis. 2014. PMID: 25321477 Free PMC article. - Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer.
Massihnia D, Avan A, Funel N, Maftouh M, van Krieken A, Granchi C, Raktoe R, Boggi U, Aicher B, Minutolo F, Russo A, Leon LG, Peters GJ, Giovannetti E. Massihnia D, et al. J Hematol Oncol. 2017 Jan 6;10(1):9. doi: 10.1186/s13045-016-0371-1. J Hematol Oncol. 2017. PMID: 28061880 Free PMC article. - Cellular metabolism hijacked by viruses for immunoevasion: potential antiviral targets.
Li J, Wang Y, Deng H, Li S, Qiu HJ. Li J, et al. Front Immunol. 2023 Jul 25;14:1228811. doi: 10.3389/fimmu.2023.1228811. eCollection 2023. Front Immunol. 2023. PMID: 37559723 Free PMC article. Review. - A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism.
Shriwas P, Roberts D, Li Y, Wang L, Qian Y, Bergmeier S, Hines J, Adhicary S, Nielsen C, Chen X. Shriwas P, et al. Cancer Metab. 2021 Mar 26;9(1):14. doi: 10.1186/s40170-021-00248-7. Cancer Metab. 2021. PMID: 33771231 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous